NeuroPace, Inc. (NPCE) Balance Sheet
As of 2026-06-30 (10-Q), NeuroPace, Inc. (NPCE) reported total assets of $97.0M, total liabilities of $85.1M and shareholders' equity of $11.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $12.5M. Long-term debt: $59.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NPCENeuroPace, Inc.Follow NPCE — free
—
Price chart with a free account
- Market cap
- 443.1M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 19.2 | 6.6 | 18.1 | 13.4 | 21.7 | 12.5 | |
| Short-term investments | 96.4 | 70.8 | 48.4 | 39.3 | 39.4 | 39.2 | |
| Receivables | 7.1 | 7.5 | 12.3 | 12.9 | 12.9 | 14.9 | |
| Inventory | 7.8 | 9.7 | 11.2 | 13.4 | 14.9 | 18.1 | |
| Current assets | 132.8 | 97.7 | 92.7 | 81.3 | 94.1 | 86.2 | |
| Total assets | 133.6 | 114.1 | 107.7 | 94.6 | 105.6 | 97.0 | |
| Current liabilities | 9.3 | 11.0 | 16.2 | 15.2 | 17.8 | 17.4 | |
| Long-term debt | 49.8 | 52.9 | 57.0 | 59.5 | 58.9 | 59.0 | |
| Short-term debt | 0.0 | — | — | — | — | — | |
| Total liabilities | 60.1 | 79.3 | 87.0 | 86.6 | 86.5 | 85.1 | |
| Shareholders' equity | 73.5 | 34.8 | 20.7 | 8.0 | 19.0 | 11.9 |
USD millions · SEC XBRL
NeuroPace, Inc. — questions
- How much cash does NeuroPace, Inc. have?
- $12.5M in cash and cash equivalents as of 2026-06-30.
- How much debt does NeuroPace, Inc. have?
- $59.0M of long-term debt as of 2026-06-30.
- What are NeuroPace, Inc.'s total assets?
- $97.0M as of 2026-06-30.
- What is NeuroPace, Inc.'s shareholders' equity?
- $11.9M as of 2026-06-30.
Every figure on this page comes from NeuroPace, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.